Analyze Diet
Developments in biologicals2003; 111; 69-76;

Collaborative study for the establishment of two European Pharmacopoeia Biological Reference Preparations for serological potency testing of tetanus vaccines for veterinary use.

Abstract: The European Directorate for the Quality of Medicines (EDQM) has organised an international collaborative study, divided into two phases, aimed at producing and establishing two suitable reference sera for serological potency testing of tetanus vaccines for veterinary use for batch consistency demonstration. In phase I pools of sera were produced by immunising guinea pigs and rabbits with tetanus toxoid using the immunisation schedule prescribed by the European Pharmacopoeia (Ph. Eur.) for potency testing of tenanus vaccines for veterinary use. Following aliquoting and freeze-drying, characterization of the materials by immunochemical and biological assays enabled us to conclude that the sera should be suitable reference materials in respect of in-vitro assay methods for Clostridium (C.) tetani. The candidate (c) Ph. Eur. Biological Reference Preparations (BRP) were calibrated by Toxin Binding Inhibition test (ToBI) in phase II of the study by a large group of laboratories, including both manufacturers and official medicines control laboratories (OMCL). The activity of the proposed reference sera was determined by comparison with the existing equine monovalent World Health Organization (WHO) International Standard (IS). This study enabled us to provide a definitive value for the antitoxin activity of the reference preparations in respect of their anti-tetanus antibody content.
Publication Date: 2003-04-08 PubMed ID: 12678226
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study focuses on the creation and verification of two reference sera for checking the potency of tetanus vaccines used in veterinary medicine, in accordance with the standards set by the European Pharmacopoeia.

Objective and Methodology of the Study

  • The European Directorate for the Quality of Medicines (EDQM) spearheaded an international study split into two phases. Its main objective was to generate and authenticate two reference sera to examine the potency of tetanus vaccines used in veterinary medicine.
  • In the first phase, pools of sera were created by immunising guinea pigs and rabbits with a tetanus toxoid adhering to the immunisation schedule set by the European Pharmacopoeia for this particular potency testing.
  • Post immunisation, the resultant materials were aliquoted (divided into smaller portions) and freeze-dried for future use.
  • These sera were then characterised using various immunochemical and biological assays, establishing their suitability as reference materials, particularly for in-vitro tests pertaining to Clostridium tetani, the bacterium causing tetanus.

Validation and Calibration of the Reference Sera

  • In the second phase of the study, the respective candidate Biological Reference Preparations (BRP) were calibrated using the Toxin Binding Inhibition Test (ToBI).
  • This calibration process involved a wide range of laboratories, including those associated with manufacturers and official medicines control laboratories (OMCL).
  • The reference sera’s anti-tetanus activity was benchmarked against the already established equine monovalent World Health Organization (WHO) International Standard (IS).
  • Thus, the study enabled the researchers to assign a precise value to the antitoxin activity of the reference preparations based on their content of anti-tetanus antibodies, therefore providing a standard for veterinary use.

Cite This Article

APA
Lensing HH, Behr-Gross ME, Daas A, Spieser JM. (2003). Collaborative study for the establishment of two European Pharmacopoeia Biological Reference Preparations for serological potency testing of tetanus vaccines for veterinary use. Dev Biol (Basel), 111, 69-76.

Publication

ISSN: 1424-6074
NlmUniqueID: 100940058
Country: Switzerland
Language: English
Volume: 111
Pages: 69-76

Researcher Affiliations

Lensing, H H
  • ID-Lelystad, Lelystad, The Netherlands.
Behr-Gross, M E
    Daas, A
      Spieser, J M

        MeSH Terms

        • Animal Testing Alternatives
        • Animals
        • Europe
        • Guinea Pigs
        • In Vitro Techniques
        • Pharmacopoeias as Topic
        • Quality Control
        • Rabbits
        • Reference Standards
        • Tetanus / immunology
        • Tetanus / prevention & control
        • Tetanus / veterinary
        • Tetanus Toxoid / immunology
        • Tetanus Toxoid / metabolism
        • Veterinary Drugs / immunology
        • Veterinary Drugs / metabolism

        Citations

        This article has been cited 0 times.